These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 15749525)

  • 1. A Markov model of the cost-effectiveness of human-derived follicle-stimulating hormone (FSH) versus recombinant FSH using comparative clinical trial data.
    Hatoum HT; Keye WR; Marrs RP; Walton SM; Marshall DC
    Fertil Steril; 2005 Mar; 83(3):804-7. PubMed ID: 15749525
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost-effectiveness of recombinant follicle-stimulating hormone (FSH) versus human FSH in intrauterine insemination cycles: a statistical model-derived analysis.
    Gerli S; Bini V; Di Renzo GC
    Gynecol Endocrinol; 2008 Jan; 24(1):18-23. PubMed ID: 18224540
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recombinant versus urinary follicle-stimulating hormone in intrauterine insemination cycles: a prospective, randomized analysis of cost effectiveness.
    Gerli S; Casini ML; Unfer V; Costabile L; Bini V; Di Renzo GC
    Fertil Steril; 2004 Sep; 82(3):573-8. PubMed ID: 15374698
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [In vitro fertilization in France: economic aspects and influence of the gonadotropin choice (urinary vs. recombinant) on cost].
    de Mouzon J; Allavena E; Schmitt C; Frappé M
    Gynecol Obstet Fertil; 2004 Jun; 32(6):508-18. PubMed ID: 15217566
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost-saving treatment strategies in in vitro fertilization: a combined economic evaluation of two large randomized clinical trials comparing highly purified human menopausal gonadotropin and recombinant follicle-stimulating hormone alpha.
    Wechowski J; Connolly M; Schneider D; McEwan P; Kennedy R
    Fertil Steril; 2009 Apr; 91(4):1067-76. PubMed ID: 18339384
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Health economic consequences of the choice of follicle stimulating hormone alternatives in IVF treatment].
    Poulsen PB; Højgaard A; Quartarolo JP
    Ugeskr Laeger; 2007 Apr; 169(14):1313-7. PubMed ID: 17437694
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Pharmacoeconomic advantages of recombinant FSH vs urinary derived FSH].
    Beresniak A
    Gynecol Obstet Fertil; 2004 Sep; 32(9):756-9. PubMed ID: 15380758
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost-effectiveness of seven IVF strategies: results of a Markov decision-analytic model.
    Fiddelers AA; Dirksen CD; Dumoulin JC; van Montfoort AP; Land JA; Janssen JM; Evers JL; Severens JL
    Hum Reprod; 2009 Jul; 24(7):1648-55. PubMed ID: 19318703
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Economic Evaluation of Three Frequently Used Gonadotrophins in Assisted Reproduction Techniques in the Management of Infertility in the Netherlands.
    Fragoulakis V; Pescott CP; Smeenk JM; van Santbrink EJ; Oosterhuis GJ; Broekmans FJ; Maniadakis N
    Appl Health Econ Health Policy; 2016 Dec; 14(6):719-727. PubMed ID: 27581117
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost-effectiveness of aromatase inhibitor co-treatment for controlled ovarian stimulation.
    Bedaiwy MA; Forman R; Mousa NA; Al Inany HG; Casper RF
    Hum Reprod; 2006 Nov; 21(11):2838-44. PubMed ID: 16877370
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost of transferring one through five embryos per in vitro fertilization cycle from various payor perspectives.
    Little SE; Ratcliffe J; Caughey AB
    Obstet Gynecol; 2006 Sep; 108(3 Pt 1):593-601. PubMed ID: 16946220
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effectiveness of highly purified human menopausal gonadotropin vs. recombinant follicle-stimulating hormone in first-cycle in vitro fertilization-intracytoplasmic sperm injection patients.
    Hompes PG; Broekmans FJ; Hoozemans DA; Schats R;
    Fertil Steril; 2008 Jun; 89(6):1685-93. PubMed ID: 17681325
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Models of cost-effectiveness of recombinant FSH versus urinary FSH.
    Al-Inany H; Afnan M
    Hum Reprod; 2002 Jun; 17(6):1671-3; author reply 1673-4. PubMed ID: 12042297
    [No Abstract]   [Full Text] [Related]  

  • 14. Impact of urinary FSH price: a cost-effectiveness analysis of recombinant and urinary FSH in assisted reproduction techniques in the USA.
    Silverberg K; Schertz J; Falk B; Beresniak A
    Reprod Biomed Online; 2002; 5(3):265-9. PubMed ID: 12470524
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recombinant follicle-stimulating hormone: new biotechnology for infertility.
    Prevost RR
    Pharmacotherapy; 1998; 18(5):1001-10. PubMed ID: 9758311
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of the cost effectiveness of recombinant versus urinary follicle-stimulating hormone in in vitro fertilization/intracytoplasmic sperm injection programs in the United States.
    Silverberg K; Daya S; Auray JP; Duru G; Ledger W; Wikland M; Bouzayen R; O'Brien M; Falk B; Beresniak A
    Fertil Steril; 2002 Jan; 77(1):107-13. PubMed ID: 11779599
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical efficacy of highly purified urinary FSH versus recombinant FSH in volunteers undergoing controlled ovarian stimulation for in vitro fertilization: a randomized, multicenter, investigator-blind trial.
    Baker VL; Fujimoto VY; Kettel LM; Adamson GD; Hoehler F; Jones CE; Soules MR
    Fertil Steril; 2009 Apr; 91(4):1005-11. PubMed ID: 18367182
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost-effectiveness of recombinant versus urinary follicle-stimulating hormone in assisted reproduction techniques in the Spanish public health care system.
    Romeu A; Balasch J; Ruiz Balda JA; Barri PN; Daya S; Auray JP; Duru G; Beresniak A; Peinado JA
    J Assist Reprod Genet; 2003 Aug; 20(8):294-300. PubMed ID: 12948090
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FSH: urinary and recombinant.
    Palagiano A; Nesti E; Pace L
    Eur J Obstet Gynecol Reprod Biol; 2004 Jul; 115 Suppl 1():S30-3. PubMed ID: 15196713
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reflections on the cost-effectiveness of recombinant FSH in assisted reproduction. The clinician's perspective.
    Balasch J; Barri PN
    J Assist Reprod Genet; 2001 Feb; 18(2):45-55. PubMed ID: 11285980
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.